| Literature DB >> 31802761 |
Roos Leguit1, Konnie Hebeda2, Marcus Kremer3, Jon van der Walt4, Umberto Gianelli5, Alexandar Tzankov6, Attilio Orazi7.
Abstract
Most cases of mastocytosis are indolent, usually cutaneous mastocytosis or indolent systemic mastocytosis (SM). Aggressive mast cell (MC) diseases are very rare and often fatal. They can develop de novo or due to progression of indolent forms and can present in different ways; either as MC sarcoma or as advanced SM which includes aggressive SM, MC leukemia, and SM with an associated hematological neoplasm. This review will describe these different aggressive forms of mastocytosis, illustrated by cases submitted to the workshop of the 18th Meeting of the European Association for Haematopathology, Basel 2016, organized by the European Bone Marrow Working Group. In addition, the diagnostic criteria for identifying myelomastocytic leukemia, an aggressive myeloid neoplasm with partial MC differentiation that falls short of the criteria for SM, and disease progression in patients with established mastocytosis are discussed. The Author(s). Published by S. Karger AG, Basel.Entities:
Keywords: Aggressive mastocytosis; Bone marrow biopsy; European Association for Haematopathology workshop; Mast cell leukemia; Mast cell sarcoma; Mastocytosis
Year: 2019 PMID: 31802761 DOI: 10.1159/000504099
Source DB: PubMed Journal: Pathobiology ISSN: 1015-2008 Impact factor: 4.342